The Food and Drug Administration announced on April 16, 2013 that it is taking two steps to address the “epidemic levels” of prescription painkiller addiction in the U.S.  First, it announced that it will not approve generic versions of the painkiller OxyContin.  In addition, the FDA approved updated labeling for OxyContin extended-release tablets to describe…